Showing results (31-40 of 66) with videos related to
Sort By:
Pageof 7
International Review of Experimental Pathology|January 1, 1993
Pharmacokinetic parameters and biodistribution of soluble cytokine receptorsC A Jacobs, M P Beckmann, K Mohler, et al.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1994
In vivo biological effects of recombinant soluble interleukin-4 receptorC R Maliszewski, T A Sato, B Davison, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
CD40-mediated signal transduction in human airway smooth muscleA L Lazaar, Y Amrani, J Hsu, et al.Seminars in Immunology|December 1, 1993
CD40L: a multi-functional ligandR J Armitage, C R Maliszewski, M R Alderson, et al.Advances in Experimental Medicine and Biology|January 1, 1991
Expression of receptors for interleukin 4 and interleukin 7 on human T cellsR J Armitage, S F Ziegler, M P Beckmann, et al.Science (New York, N.Y.)|May 11, 1990
Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptorW C Fanslow, J E Sims, H Sassenfeld, et al.The Journal of Experimental Medicine|February 1, 1996
bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic miceD A Grillot, R Merino, J C Pena, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1994
Recombinant CD40 ligand exerts potent biologic effects on T cellsW C Fanslow, K N Clifford, M Seaman, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1995
Human IL-17: a novel cytokine derived from T cellsZ Yao, S L Painter, W C Fanslow, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 14, 1998
CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosisA Campos-Neto, P Ovendale, T Bement, et al.Pageof 7